Ethosome: An Innovative Perspective of Drug Delivery.
| Title: | Ethosome: An Innovative Perspective of Drug Delivery. |
|---|---|
| Authors: | Lohakare NS; K.K. Wagh College of Pharmacy, Nashik, Maharashtra, India.; Bhamare VG; Department of Pharmaceutics, K. K. Wagh College of Pharmacy, Nashik, Maharashtra, India.; Chavan ND; K.K. Wagh College of Pharmacy, Nashik, Maharashtra, India.; Shelar SD; K.K. Wagh College of Pharmacy, Nashik, Maharashtra, India.; Mahajan HD; K.K. Wagh College of Pharmacy, Nashik, Maharashtra, India.; Amrutkar RD; Department of Pharmaceutical Chemistry, K. K. Wagh College of Pharmacy, Nashik, Maharashtra, India. |
| Source: | Pharmaceutical nanotechnology [Pharm Nanotechnol] 2025; Vol. 13 (4), pp. 712-725. |
| Publication Type: | Journal Article; Review |
| Language: | English |
| Journal Info: | Publisher: Bentham Science Country of Publication: United Arab Emirates NLM ID: 101623431 Publication Model: Print Cited Medium: Internet ISSN: 2211-7393 (Electronic) Linking ISSN: 22117385 NLM ISO Abbreviation: Pharm Nanotechnol Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Saif Zone, Sharjah, U.A.E. : Bentham Science, [2013]- |
| MeSH Terms: | Drug Delivery Systems*/methods ; Drug Carriers*/chemistry ; Nanoparticles*/chemistry; Liposomes/chemistry ; Skin/metabolism ; Humans ; Skin Absorption ; Animals ; Administration, Cutaneous |
| Abstract: | Ethosome offers a unique solution to the challenges faced by conventional drug delivery systems. In comparison to traditional liposomes and other nanocarriers, ethosomes exhibit a unique ability to improve drug absorption, overcoming a major limitation in the Transdermal Drug Delivery System. Their soft and flexible nano-vesicular structure facilitates faster permeation, resulting in significantly higher transdermal flux. This scientific investigation effectively traverses the changing landscape of ethosomes as an innovative drug delivery system. By conducting a thorough comparative analysis, we uncover the distinct characteristics that set them apart from other nanocarriers, offering insights into their distinct advantages. The study also includes a detailed analysis of the variables that have a complex impact on performance, elucidating transport mechanisms and addressing advanced facets pivotal for refined drug delivery strategies. This comprehensive overview highlights ethosomes as a future of medicine, offering a promising future for the safe and effective treatment of diverse diseases, impacting numerous lives.; (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.) |
| References: | Chauhan N.; Vasava P.; Khan S.L.; Ethosomes: Anovel drug carrier. Ann Med Surg 2022,82,104595. (PMID: 10.1016/j.amsu.2022.10459536124209); Patrekar P.V.; Inamdar S.J.; Mali S.S.; Mujib M.T.; Ahir A.A.; Hosmani A.H.; Ethosomes as novel drug delivery system: Areview. Pharma Innov 2015,4(9, Part A),10.; Chauhan AS; Pandey GK; Joshi A; Dubey BK; Jain P; A review on Ethosome: Anovel drug delivery system for topical fungal disease. pharma innov j 2018,7(12),355-62.; Grossi L.N.; Braz W.R.; da Silva N.P.; Ethosomes as a delivery system for treatment of melanoma: Amini-review. Oncology 2023,25(5),455-459.; Monisha C.; Ganesh G.; Mythili L.; Radhakrishnan K.; A review on ethosomes for transdermal application. Res J Pharm Technol 2019,12(7),3133-3143. (PMID: 10.5958/0974-360X.2019.00529.8); Anitha P; Ramkanth S; Sankari KU; Ethosomes : Anoninvasive vesicular carrier for transdermal drug delivery. Int j rev life sci 2011,201(1),1.; Nandure HP; Puranik P; Giram P; Lone V; Ethosome: Anovel drug carrier. Int j pharmac res all sci 2013,2(3),6-12.; Rajender M; Ethosomes as novel drug delivery carriers : Areview. Indo AmJ P Sci 2016,3(12).; Liu X.; Liu H.; Liu J.; Preparation of a ligustrazine ethosome patch and its evaluation in vitro and in vivo. Int J Nanomedicine 2011,6,241-247. (PMID: 10.2147/IJN.S1604421499422); Mehetre N.M.; Singh I.; Therapeutic carriers for the vaginal delivery of anti-hiv drug. Int J Pharm Sci Res 2022,16(2),543-558. (PMID: 10.13040/IJPSR.09758232.13(2).543-58); Satyam G.; Shivani S.; Garima G.; Ethosomes: Anovel tool for drug delivery through the skin. J Pharm Res 2010,3(4),688-691.; Rada S.K.; Yadav S.; Ethosomes: Anovel approach in vesicular drug delivery systems. J Pharm Res Int 2022,34(28B),62-71. (PMID: 10.9734/jpri/2022/v34i28B36036); Ramakrishna GA; Manobar SD; Bhanudas SR; Ethosomes: carrier for enhanced transdermal drug delivery system. circulation 2014,1(2).; Garg V.; Singh H.; Bimbrawh S.; Ethosomes and transfersomes: Principles, perspectives and practices. Curr Drug Deliv 2017,14(5),613-633. (PMID: 27199229); Savoire R.; Subra-Paternault P.; Bardeau T.; Morvan E.; Grélard A.; Cansell M.; Selective extraction of phospholipids from food by-products by supercritical carbon dioxide and ethanol and formulating ability of extracts. Separ Purif Tech 2020,238,116394. (PMID: 10.1016/j.seppur.2019.116394); Esposito E.; Drechsler M.; Nastruzzi C.; Cortesi R.; Cubic phases, cubosomes and ethosomes for cutaneous application. Curr Pharm Des 2016,22(35),5382-5399. (PMID: 10.2174/138161282266616072612322727839503); Ainbinder D.; Paolino D.; Fresta M.; Touitou E.; Drug delivery applications with ethosomes. J Biomed Nanotechnol 2010,6(5),558-568. (PMID: 10.1166/jbn.2010.115221329048); Touitou E.; Dayan N.; Bergelson L.; Godin B.; Eliaz M.; Ethosomes novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 2000,65(3),403-418. (PMID: 10.1016/S0168-3659(99)00222-910699298); Sudhakar K.; Ultraflexible liposome nanocargo as a dermal and transdermal drug delivery system Nanomaterials 2021,11.10,2557.; Mozafari M.R.; Liposomes: An overview of manufacturing techniques. Cell Mol Biol Lett 2005,10(4),711-719. (PMID: 16341279); Singh N.; Gautam S.P.; Kumari N.; Kaur R.; Kaur M.; Virosomes as novel drug delivery system: An overview. PharmaTutor 2017,5(9),47-55.; Rossier-Miranda F.J.; Schroën C.G.P.H.; Boom R.M.; Colloidosomes: Versatile microcapsules in perspective. Colloids Surf A Physicochem Eng Asp 2009,343(1-3),43-49. (PMID: 10.1016/j.colsurfa.2009.01.027); Shahabade Gururaj S.; Bhosale Ashok V.; Mutha Swati S.; An overview on nanocarrier technology-Aquasomes. J Pharm Res 2009,2(7),1174-1177.; Wakaskar R.R.; General overview of lipid–polymer hybrid nanoparticles, dendrimers, micelles, liposomes, spongosomes and cubosomes. J Drug Target 2018,26(4),311-318. (PMID: 10.1080/1061186X.2017.136700628797169); Bharatia R.; Kumar S.; Chaursiya S.; Gautam K.M.; Bharti S.; Varun R.; Sphingosomes: Anovel vesicular drug delivery system. Int J Pharma ProfessRes 2023,14(3),88-93. (PMID: 10.48165/ijppronline.2023.14308); Al-kaf AG; Othman AM; Pharmacosomes: An updated review. Univ j pharmac res 2017,2(1),30-33.; Dubey V.; Mishra D.; Jain N.K.; Melatonin loaded ethanolic liposomes: Physicochemical characterization and enhanced transdermal delivery. Eur J Pharm Biopharm 2007,67(2),398-405. (PMID: 10.1016/j.ejpb.2007.03.00717452098); Mostafa D.A.; Hashad A.M.; Abdelreheem A.Y.; A novel vesicular lipid carrier systems to enhance acyclovir delivery through skin. Int J Pharm Res Allied Sci 2018,7,209.; Chen J.G.; Jiang Y.; Yang Z.B.; Preparation of triptolide ethosomes. Afr J Pharm Pharmacol 2012,6(13),998-1004.; Pandey V.; Golhani D.; Shukla R.; Ethosomes: versatile vesicular carriers for efficient transdermal delivery of therapeutic agents. Drug Deliv 2015,22(8),988-1002. (PMID: 10.3109/10717544.2014.88977724580572); David S.R.; Hui M.S.; Pin C.F.; Ci F.Y.; Rajabalaya R.; Formulation and in vitro evaluation of ethosomes as vesicular carrier for enhanced topical delivery of isotretinoin. Int J Drug Deliv 2013,5(1),28.; Jin-guang C.H.E.N.; Preparation of curcumin ethosomes. Afr J Pharm Pharmacol 2013,7(31),2246-2251. (PMID: 10.5897/AJPP12.435); Bodade S.S.; Shaikh K.S.; Kamble M.S.; Chaudhari P.D.; A study on ethosomes as mode for transdermal delivery of an antidiabetic drug. Drug Deliv 2013,20(1),40-46. (PMID: 10.3109/10717544.2012.75242023311652); Jain S.; Umamaheshwari R.B.; Bhadra D.; Jain N.K.; Ethosomes: Anovel vesicular carrier for enhanced transdermal delivery of an antiHIV agent. Indian J Pharm Sci 2004,66(1),72-81.; Dave V.; Sohgaura A.; Tak K.; Ethosomal polymeric patch containing losartan potassium for the treatment of hypertension: in-vitro and in-vivo evaluation. Biomed Phys Eng Express 2019,5(6),065029. (PMID: 10.1088/2057-1976/ab4fa4); Wong W.F.; Ang K.P.; Sethi G.; Looi C.Y.; Recent advancement of medical patch for transdermal drug delivery. Medicina) 2023,59(4),778. (PMID: 10.3390/medicina5904077837109736); Sinko S.; Aljuhani A.; Ehtezazi T.; Ethosomal nanocarriers for the topical delivery of flurbiprofen: Physicochemical characterization and in vitro permeation studies. J Drug Deliv Sci Technol 2021,112,104024.; Jain S.; Patel N.; Madan P.; Lin S.; Quality by design approach for formulation, evaluation and statistical optimization of diclofenac-loaded ethosomes via transdermal route. Pharm Dev Technol 2015,20(4),473-489. (PMID: 10.3109/10837450.2014.88293924490793); Gad S.; mousa, Hamadi T, sayed O. An evaluation of the effects of ethosomes in the delivery of transdermal drugs. Rec Pharmac Biomed Sci 2022,6(3),120-127. (PMID: 10.21608/rpbs.2022.141371.1147); Gupta A.; Acyclovir Ethosomes Design, Characterization And Release Study.; Touitou E.; Godin B.; Ethosomes for skin delivery. J Drug Deliv Sci Technol 2007,17(5),303-308. (PMID: 10.1016/S1773-2247(07)50046-8); Esposito E.; Calderan L.; Galvan A.; Ex Vivo evaluation of ethosomes and transethosomes applied on human skin: A comparative study. Int J Mol Sci 2022,23(23),15112. (PMID: 10.3390/ijms23231511236499432); Opatha S.A.T.; Titapiwatanakun V.; Chutoprapat R.; Transfersomes: Apromising nanoencapsulation technique for transdermal drug delivery. Pharmaceutics 2020,12(9),855. (PMID: 10.3390/pharmaceutics1209085532916782); Abdulbaqi I.M.; Darwis Y.; Khan N.A.; Assi R.A.; Khan A.A.; Ethosomal nanocarriers: The impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials. Int J Nanomedicine 2016,11,2279-2304. (PMID: 10.2147/IJN.S10501627307730); Patwekar S.L.; Khavane K.B.; Chainpure P.R.; Shivpuje S.A.; A review on different preparation methods used for development of curcumin nanoparticles. Int J Creat ResThoug 2021,9(1),4088-4101.; Suzuki K.; Tanaka N.; Ando A.; Takagi H.; Optical properties and fabrication of cuprous oxide nanoparticles by microemulsion method. J Am Ceram Soc 2011,94(8),2379-2385. (PMID: 10.1111/j.1551-2916.2011.04413.x); Jantrawut P.; Boonsermsukcharoen K.; Thipnan K.; Chaiwarit T.; Hwang K.M.; Park E.S.; Enhancement of antibacterial activity of orange oil in pectin thin film by microemulsion. Nanomaterials 2018,8(7),545. (PMID: 10.3390/nano807054530029478); Mohammed M.I.; Makky A.M.; Abdellatif M.M.; Formulation and characterization of ethosomes bearing vancomycin hydrochloride for transdermal delivery. Int J Pharm Pharm Sci 2014,190-194.; Zhai Y.; Xu R.; Wang Y.; Liu J.; Wang Z.; Zhai G.; Ethosomes for skin delivery of ropivacaine: preparation, characterization and ex vivo penetration properties. J Liposome Res 2015,25(4),316-324. (PMID: 10.3109/08982104.2014.99968625625544); Manikkath J.; Hegde A.R.; Parekh H.S.; Mutalik S.; Peptide dendrimers in delivery of bioactive molecules to skin. Nanosci Dermatol 2016,89-97. (PMID: 10.1016/B978-0-12-802926-8.00007-0); Zahid S.R.; Upmanyu N.; Dangi S.; Ray S.K.; Jain P.; Parkhe G.; Ethosome: Anovel vesicular carrier for transdermal drug delivery. J Drug Deliv Ther 2018,8(6),318-326. (PMID: 10.22270/jddt.v8i6.2028); Prausnitz M.R.; Langer R.; Transdermal drug delivery. Nat Biotechnol 2008,26(11),1261-1268. (PMID: 10.1038/nbt.150418997767); Jaiswal P.K.; Kesharwani S.; Kesharwani R.; Patel D.K.; Ethosome: Anew technology used as topical and transdermal delivery system. J Drug Deliv Ther 2016,6(3),7-17. (PMID: 10.22270/jddt.v6i3.1245); Zahid A.A.; Chakraborty A.; Luo W.; Coyle A.; Paul A.; Tailoring the inherent properties of biobased nanoparticles for nanomedicine. ACS Biomater Sci Eng 2023,9(7),3972-3986. (PMID: 10.1021/acsbiomaterials.3c0036437378614); Ahad A.; Akhtar N.; Gupta D.K.; In: Systems of Nanovesicular Drug Delivery 2022,221-237. (PMID: 10.1016/B978-0-323-91864-0.00003-6); Ali S; Shabbir M; Shahid N; The structure of skin and transdermal drug delivery system: A review Res j pharm technol 2015,8(2),103-9. (PMID: 10.5958/0974-360X.2015.00019.0); Meesa R.; Srinivas A.; Chandrasekhar K.B.; Design and characterization of delavirdine ethosomal drug delivery to enhance the bioavailability via topical drug delivery. Int J Health Sci 2022(II),11178-11197. (PMID: 10.53730/ijhs.v6nS2.8015); Rao B.N.; Reddy K.R.; Mounika B.; Fathima S.R.; Tejaswini A.; Vesicular drug delivery system: Areview. Int J Chemtech Res 2019,12(5),39-53. (PMID: 10.20902/IJCTR.2019.120505); Kamboj S; Saini V; Magon N; Bala S; Jhawat V; Vesicular drug delivery systems: A novel approach for drug targeting. brain 2013,1(11),1-8.; Wahid A.A.; Ravouru N.; Lakshman S.R.; Ethosomes: Atool for transdermal drug delivery. Curr Trends Biotechnol Pharm 2011,5(1),972-981.; Nainwal N.; Jawla S.; Singh R.; Saharan V.A.; Transdermal applications of ethosomes a detailed review. J Liposome Res 2019,29(2),103-113. (PMID: 10.1080/08982104.2018.151716030156120); Lu J.; Guo T.; Fan Y.; Recent developments in the principles, modification and application prospects of functionalized ethosomes for topical delivery. Curr Drug Deliv 2021,18(5),570-582. (PMID: 10.2174/156720181766620082609310232851961); Paliwal S.; Tilak A.; Sharma J.; Flurbiprofen loaded ethosomes transdermal delivery of anti-inflammatory effect in rat model. Lipids Health Dis 2019,18(1),133. (PMID: 10.1186/s12944-019-1064-x30611256); Maurya S.D.; Prajapati S.; Gupta A.; Saxena G.; Dhakar R.C.; Formulation development and evaluation of ethosome of stavudine. Int J Pharm Edu Res 2010,13,16.; Sguizzato M.; Ferrara F.; Hallan S.S.; Ethosomes and transethosomes for mangiferin transdermal delivery. Antioxidants 2021,10(5),768. (PMID: 10.3390/antiox1005076834066018); Limsuwan T.; Boonme P.; Khongkow P.; Amnuaikit T.; Ethosomes of phenylethyl resorcinol as vesicular delivery system for skin lightening applications. BioMed Res Int 2017,2017,1-12. (PMID: 10.1155/2017/831097928804723); Mousa I.A.; Hammady T.M.; Gad S.; Zaitone S.A.; El-Sherbiny M.; Sayed O.M.; Formulation and characterization of metformin-loaded ethosomes for topical application to experimentally induced skin cancer in mice. Pharmaceuticals 2022,15(6),657. (PMID: 10.3390/ph1506065735745575); Ramteke S.; Barupal A.K.; Gupta V.; Preparation and characterization of ethosomes for topical delivery of aceclofenac. Indian J Pharm Sci 2010,72(5),582-586. (PMID: 10.4103/0250-474X.7852421694989); Jain S.; Tiwary A.K.; Sapra B.; Jain N.K.; Formulation and evaluation of ethosomes for transdermal delivery of lamivudine. AAPS PharmSciTech 2007,8(4),249. (PMID: 10.1208/pt080411118181532); Sicurella M.; Pula W.; Musiał K.; Ethosomal gel for topical administration of dimethyl fumarate in the treatment of HSV-1 infections. Int J Mol Sci 2023,24(4),4133. (PMID: 10.3390/ijms2404413336835541); Gupta N.B.; Loona S.; Khan M.U.; Ethosomes as elastic vesicles in transdermal drug delivery: An overview. Int J Pharm Sci Res 2012,3(3),682.; Rathore G.S.; Tanwar Y.S.; Sharma A.; Fluconazole loaded ethosomes gel and liposomes gel: an updated review for the treatment of deep fungal skin infection. Pharm Chem J 2015,2(1),41-50.; Godin B.; Touitou E.; Ethosomes: new prospects in transdermal delivery. Crit Rev Ther Drug Carrier Syst 2003,20(2-3),153-214. (PMID: 10.1615/CritRevTherDrugCarrierSyst.v20.i1.20); Chandra A.; Aggarwal G.; Manchanda S.; Narula A.; Development of topical gel of methotrexate incorporated ethosomes and salicylic acid for the treatment of psoriasis. Pharm Nanotechnol 2019,7(5),362-374. (PMID: 10.2174/221173850766619090612364331490769); Saraf S.; Kumar Gupta M.; Itraconazole loaded ethosomal gel system for efficient treatment of skin cancer. Int J Drug Deliv 2018,10(1),12-19. (PMID: 10.5138/09750215.2246); Nair R.S.; Billa N.; Leong C.O.; Morris A.P.; An evaluation of tocotrienol ethosomes for transdermal delivery using Strat-M ® membrane and excised human skin. Pharm Dev Technol 2021,26(2),243-251. (PMID: 10.1080/10837450.2020.186008733274672); Ferrara F.; Benedusi M.; Sguizzato M.; Ethosomes and transethosomes as cutaneous delivery systems for quercetin: A preliminary study on melanoma cells. Pharmaceutics 2022,14(5),1038. (PMID: 10.3390/pharmaceutics1405103835631628); Abubakr A.H.; Ibrahem A.E.; Salah M.; Ethosomes: A potential nanocarrier for transdermal drug delivery. ERU Res J 2023,2(1),161-176.; Verma P.; Pathak K.; Therapeutic and cosmeceutical potential of ethosomes: An overview. J Adv Pharm Technol Res 2010,1(3),274-282. (PMID: 10.4103/0110-5558.7241522247858); Wahyuningtyas R.; Kurniawati E.M.; Utomo B.; License. Available from: http://creativecommons. org/licenses/by/4.0/ which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.; Xiao-Fei L.I.A.N.G.; Jing-Ying H.U.; Fu-Hua C.H.E.N.; Zong-Hai L.I.; Jin C.H.A.N.G.; Characterization of chitosan polymeric ethosomes capable of encapsulating hydrophobic and hydrophilic drugs prepared by a microemulsion method. Wuli Huaxue Xuebao 2012,28(4),897-902. (PMID: 10.3866/PKU.WHXB201202091); Madhavi B.B.; Vennela K.S.; Masana P.; Madipoju B.; Enhanced transdermal drug penetration of curcumin via ethosomes. Malays J Pharm Sci 2013,11(1),49.; Wenfeng D; Peng Y; Zhang C; Ceramide ethosome and preparation method and application thereof. Patent CN115919680A 2022.; Heng LI; Jianxin XU; Composite volatile oil ethosome and preparation method thereof Patent CN115843864A 2022.; Nana Y.; Tropisetron hydrochloride ethosome gel plaster and preparation method thereof Patent CN114617859A 2022.; Ahmed T.A.; Alzahrani M.M.; Alhakamy N.A.; Felimban R.I.; Inventors; King Abdulaziz University, assignee. Ketoconazole ophthalmic preparations containing trans-ethosomal drug nanoparticles. patent US11285148, 2022.; Yongtai Z; Niaping F; Hongyu Z; Zhi W; Teng G; Xiaolin H; Hyaluronic acid modified ethosome, acupoint drug delivery system containing same and application of system. Patent CN114288248A, 2021.; Kim Y.M.; Jang G.H.; Inventors; Binotec Co Ltd, assignee. Method of preparing bioactive substance-encapsulated ethosome, ethosome composition and cosmetic composition including ethosome composition. patent US11452679, 2022.; Ho KJ; Yong JJ; Ethosomal composition including ethosomes encapsulating vitamin and dexpanthenol and method for preparing the same. Patent AU2020389480A1 2020.; Shenquan L; Mingfei S; Nanshan QI; Selamectin ethosome preparation and preparation method and application thereof. Patent CN110680803A1 2019.; Lin G; Fu X; Wang H.; Thymosin beta-4 ethosome and preparation process thereof. Patent CN108721604B 2018.; Du Q; Chen Q; Jin P; Antioxidant nanometer ethosome rose essence and preparation method thereof. Patent CN106880505B 2017.; Qizhen DU; Yuanyuan Y; Weihua Z; Qing C; Release controlled nanometer ethosome essence and preparation method thereof. Patent CN106753789B 2016.; Klokkers K.; A kind of tetracaine ethosome and its preparation technology. Patent CN106474065A 2016.; Wang H; Yang X; Lin SI; Yu F; Chen M; Fan L; Preparation method of ethosome/natural material/polyvinyl alcohol composite hydrogel. Patent CN104706571A 2015.; Jie C; Changping H; Maoxin Z; Kaipin N; Ethosome gel filmcoating agent with multiple wound repair effects and preparation method of ethosome gel film-coating agent Patent CN103893394A 2014.; Ping B; Rong H; Lin C; Rong W; Huanhuan W; Xiaoli H; Chinese medicinal ethosome gel patch for treating herpes zoster and preparation method thereof Patent CN103536700A 2014.; Xianying Z; Yongping S; Jining G; Yimin L; Huawen Z; Xiang X; Lidocaine ethosome and preparation method thereof Patent CN102813624A 2012.; Zhang S; Deng H; Lin H; Zhang X; Progesterone ethosome and preparation method and application thereof Patent CN102397255A 2012.; Nianping YY; Jihui Z; Haiting W; Xiaoqin S; Podophyllotoxin ethosomes and preparation methods thereof Patent CN102144972A 2010.; Wadher K.; Pounikar S.D.; Trivedi S.; Umekar M.; Ethosome: A novel vesicular carrier. Int J Innov Res Adv Stud 2018,5,13-20.; Faustino C.; Pinheiro L.; Lipid systems for the delivery of amphotericin b in antifungal therapy. Pharmaceutics 2020,12(1),29. (PMID: 10.3390/pharmaceutics1201002931906268); Kolimi P.; Innovative treatment strategies to accelerate wound healing: trajectory and recent advancements Cells 2022,11.15,2439.; Google Parents Available from: https://patents.google.com/ (accessed Dec 07, 2023).; Ahmed S.; Sarim Imam S.; Zafar A.; Ali A.; Aqil M.; Gull A.; in vitro and preclinical assessment of factorial design based nanoethosomes transgel formulation of an opioid analgesic. Artif Cells Nanomed Biotechnol 2016,44(8),1793-1802. (PMID: 10.3109/21691401.2015.110274226584819); Akhtar N.; Pathak K.; Preclinical and clinical aspects of antimicrobial drugs delivered through ethosomal vesicles. Antiinfect Agents 2012,10(1),15-25.; Costanzo M.; Formulative study and intracellular fate evaluation of ethosomes and transethosomes for vitamin D3 delivery. Int j molec sci 2021,22.10,5341.; Ahad A.; Aqil M.; Kohli K.; Sultana Y.; Mujeeb M.; Nano vesicular lipid carriers of angiotensin II receptor blocker: Anti-hypertensive and skin toxicity study in focus. Artif Cells Nanomed Biotechnol 2016,44(3),1002-1007. (PMID: 25707444); Alshehri S.; Hussain A.; Altamimi M.A.; Ramzan M.; in vitro, ex vivo, and in vivo studies of binary ethosomes for transdermal delivery of acyclovir: Acomparative assessment. J Drug Deliv Sci Technol 2021,62,102390. (PMID: 10.1016/j.jddst.2021.102390); Shakibaie M.; Shahverdi A.R.; Faramarzi M.A.; Hassanzadeh G.R.; Rahimi H.R.; Sabzevari O.; Acute and subacute toxicity of novel biogenic selenium nanoparticles in mice. Pharm Biol 2013,51(1),58-63. (PMID: 10.3109/13880209.2012.71024123035822); Santos A.C.; Morais F.; Simões A.; Nanotechnology for the development of new cosmetic formulations. Expert Opin Drug Deliv 2019,16(4),313-330. (PMID: 10.1080/17425247.2019.158542630793641); Salem H.F.; Kharshoum R.M.; Abou-Taleb H.A.; AbouTaleb H.A.; AbouElhassan K.M.; Progesterone-loaded nanosized transethosomes for vaginal permeation enhancement: formulation, statistical optimization, and clinical evaluation in anovulatory polycystic ovary syndrome. J Liposome Res 2019,29(2),183-194. (PMID: 10.1080/08982104.2018.152448330221566); Paiva-Santos A.C.; Silva A.L.; Guerra C.; Ethosomes as nanocarriers for the development of skin delivery formulations. Pharm Res 2021,38(6),947-970. (PMID: 10.1007/s11095-021-03053-534036520); Bellefroid C.; Lechanteur A.; Evrard B.; Mottet D.; Debacq-Chainiaux F.; Piel G.; in vitro skin penetration enhancement techniques: Acombined approach of ethosomes and microneedles. Int J Pharm 2019,572,118793. (PMID: 10.1016/j.ijpharm.2019.11879331715350); Devaki J.; Pavuluri S.; Suma N.; Ethosomes: A vesicular carrier as a novel tool for transdermal drug delivery system. J Drug Deliv Ther 2023,13(4),159-164. (PMID: 10.22270/jddt.v13i4.5796); Malik M.A.; Wani M.Y.; Hashim M.A.; Microemulsion method: Anovel route to synthesize organic and inorganic nanomaterials. Arab J Chem 2012,5(4),397-417. (PMID: 10.1016/j.arabjc.2010.09.027); Urbaniak T.; Musiał W.; Influence of solvent evaporation technique parameters on diameter of submicron lamivudine-poly-ε-caprolactone conjugate particles. Nanomaterials 2019,9(9),1240. (PMID: 10.3390/nano909124031480469); Schultz S.; Wagner G.; Urban K.; Ulrich J.; High‐pressure homogenization as a process for emulsion formation. Ind ChemPlant EquipProc EngBiotechno 2004,27(4),361-368.; Khan M.S.; Mohapatra S.; Gupta V.; Potential of lipid-based nanocarriers against two major barriers to drug delivery skin and blood brain barrier. Membranes 2023,13(3),343. (PMID: 10.3390/membranes1303034336984730); Valsalan Soba S.; Babu M.; Panonnummal R.; Ethosomal gel formulation of alpha phellandrene for the transdermal delivery in gout. Adv Pharm Bull 2020,11(1),137-149. (PMID: 10.34172/apb.2021.01533747861); Zhao C.; Quan P.; Liu C.; Li Q.; Fang L.; Effect of isopropyl myristate on the viscoelasticity and drug release of a drug-in-adhesive transdermal patch containing blonanserin. Acta Pharm Sin B 2016,6(6),623-628. (PMID: 10.1016/j.apsb.2016.05.01227818930); Hmingthansanga V.; Singh N.; Banerjee S.; Manickam S.; Velayutham R.; Natesan S.; Improved topical drug delivery: Role of permeation enhancers and advanced approaches. Pharmaceutics 2022,14(12),2818. (PMID: 10.3390/pharmaceutics1412281836559311); Som I.; Bhatia K.; Yasir M.; Status of surfactants as penetration enhancers in transdermal drug delivery. J Pharm Bioallied Sci 2012,4(1),2-9. (PMID: 10.4103/0975-7406.9272422368393); Cu Y.; Saltzman W.M.; Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus. Mol Pharm 2009,6(1),173-181. (PMID: 10.1021/mp800125419053536); Nosova A.S.; Koloskova O.O.; Nikonova A.A.; Diversity of PEGylation methods of liposomes and their influence on RNA delivery. MedChemComm 2019,10(3),369-377. (PMID: 10.1039/C8MD00515J31015904); Emam S.E.; Elsadek N.E.; Shimizu T.; Ishida T.; 2023,159-172. (PMID: 10.1007/978-1-0716-2954-3_14); Abreu-Rejón A.D.; Herrera-Kao W.A.; May-Pat A.; Influence of molecular weight and grafting density of PEG on the surface properties of polyurethanes and their effect on the viability and morphology of fibroblasts and osteoblasts. Polymers 2022,14(22),4912. (PMID: 10.3390/polym1422491236433040) |
| Contributed Indexing: | Keywords: Ethosomes; drug delivery system; nanocarrier; phospholipid; stratum corneum; vesicles. |
| Substance Nomenclature: | 0 (Liposomes); 0 (Drug Carriers) |
| Entry Date(s): | Date Created: 20240529 Date Completed: 20250917 Latest Revision: 20250917 |
| Update Code: | 20260130 |
| DOI: | 10.2174/0122117385303596240513053014 |
| PMID: | 38808706 |
| Database: | MEDLINE |
Journal Article; Review